Drug development in preeclampsia: a 'no go' area?

Drug development in preeclampsia: a 'no go' area?

Item
http://www.wikidata.org/entity/Q46328251
Treatment of poor placentation and the prevention of associated adverse outcomes--what does the future hold?A Dormant Microbial Component in the Development of PreeclampsiaThe Role of Statins in Prevention of Preeclampsia: A Promise for the Future?The nitric oxide pathway and possible therapeutic options in pre-eclampsiaS-Nitrosoglutathione improves haemodynamics in early-onset pre-eclampsia.Pre-eclampsia: the Potential of GSNO Reductase Inhibitors.Thrombosis during pregnancy: Risks, prevention, and treatment for mother and fetus--harvesting the power of omic technology, biomarkers and in vitro or in vivo models to facilitate the treatment of thrombosis.Upcoming drugs for the treatment of preeclampsia in pregnant women.Body mass index and the risk of hypertensive disorders of pregnancy: the great obstetrical syndromes (GOS) study.Maternal cytoglobin (CYGB) serum levels in normal and preeclamptic pregnancies.
P2860

Drug development in preeclampsia: a 'no go' area?

Item
http://www.wikidata.org/entity/Q46328251
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Drug development in preeclampsia: a 'no go' area?
@en
Drug development in preeclampsia: a 'no go' area?
@nl
type
label
Drug development in preeclampsia: a 'no go' area?
@en
Drug development in preeclampsia: a 'no go' area?
@nl
prefLabel
Drug development in preeclampsia: a 'no go' area?
@en
Drug development in preeclampsia: a 'no go' area?
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Drug development in preeclampsia: a 'no go' area?
@en
P2093
P2860
P304
P31
P356
10.3109/14767058.2011.557791
P433
P478
P577
P698
P921